Please try another search
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through two segments, Beyond Air and Beyond Cancer. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. In addition, the company develops ultra-high concentration NO in Phase 1 clinical trial to treat solid tumors. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
Name | Age | Since | Title |
---|---|---|---|
Steven Adam Lisi | 51 | 2017 | CEO & Chairman of the Board |
William P. Forbes | 62 | 2018 | Independent Director |
Robert F. Carey | 65 | 2019 | Independent Director |
David Greenberg | 64 | - | Member of Scientific Advisory Board |
Andrew R. Colin | - | 2013 | Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board |
Hannah Blau | - | - | Member of Scientific Advisory Board |
Yoori Lee | 50 | 2018 | Independent Director |
Erick J. Lucera | 56 | 2017 | Independent Director |
Yossef Av-Gay | 62 | 2011 | Member of Scientific Advisory Board |
Richard Malley | - | - | Member of Scientific Advisory Board |
Ron Bentsur | 58 | 2017 | Independent Director |
Stacey Martiniano | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review